We are live on ! Find out more
SWTX

SpringWorks Therapeutics
SWTX

Delisted

SWTX was delisted on the 30th of June, 2025.

Back to rankings

137 hedge funds and large institutions have $3.23B invested in SpringWorks Therapeutics in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 51 increasing their positions, 46 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

108% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 12

11% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 46

10% more funds holding

Funds holding: 124 → 137 (+13)

3% more capital invested

Capital invested by funds: $3.13B → $3.23B (+$103M)

0.72% more ownership

Funds ownership: 88.96% → 89.68% (+0.72%)

14% less funds holding in top 10

Funds holding in top 10: 7 → 6 (-1)

Holders
137
Holders Change
+13
Holders Change %
+10.48%
% of All Funds
2.41%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.11%
New
25
Increased
51
Reduced
46
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$95.8M
2
PA
Perceptive Advisors
New York
+$52.6M
3
Bank of America
Bank of America
North Carolina
+$38.6M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$32.4M
5
CCM
Consonance Capital Management
New York
+$24.1M

Top Sellers

Rank Fund Capital Flow
1
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
-$114M
2
O
OrbiMed
New York
-$95.5M
3
DM
Deerfield Management
New York
-$69.3M
4
Goldman Sachs
Goldman Sachs
New York
-$16.1M
5
ACH
ArrowMark Colorado Holdings
Colorado
-$11.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
MLICM
101
Metropolitan Life Insurance Company (MetLife)
New York
$474K -$17K -217 -3%
ASN
102
Advisory Services Network
Georgia
$430K – – –
DCM
103
Dupont Capital Management
Delaware
$418K -$91.4K -1,167 -17%
ASRS
104
Arizona State Retirement System
Arizona
$418K +$9.4K +120 +2%
Public Employees Retirement Association of Colorado
105
Public Employees Retirement Association of Colorado
Colorado
$337K – – –
AQR Capital Management
106
AQR Capital Management
Connecticut
$297K +$317K +4,042 New
VEA
107
Virtus ETF Advisers
New York
$295K +$5.17K +66 +2%
M&T Bank
108
M&T Bank
New York
$264K -$238K -3,034 -46%
Qube Research & Technologies (QRT)
109
Qube Research & Technologies (QRT)
United Kingdom
$257K +$274K +3,499 New
AB
110
Amalgamated Bank
New York
$250K -$26.6K -340 -9%
Royal Bank of Canada
111
Royal Bank of Canada
Ontario, Canada
$231K +$178K +2,269 +260%
Los Angeles Capital Management
112
Los Angeles Capital Management
California
$207K +$220K +2,815 New
Stifel Financial
113
Stifel Financial
Missouri
$202K -$734K -9,374 -77%
AIP
114
Ameritas Investment Partners
Nebraska
$148K – – –
MAM
115
Meeder Asset Management
Ohio
$127K +$134K +1,712 New
Rockefeller Capital Management
116
Rockefeller Capital Management
New York
$108K +$116K +1,478 New
Canada Life
117
Canada Life
Manitoba, Canada
$95K +$31.2K +398 +44%
PCM
118
Penserra Capital Management
California
$81K -$1.18K -15 -1%
Pacer Advisors
119
Pacer Advisors
Pennsylvania
$73K -$25.2K -322 -25%
Bank of Montreal
120
Bank of Montreal
Ontario, Canada
$68K -$220K -2,805 -75%
TRCT
121
Tower Research Capital (TRC)
New York
$61K -$9.55K -122 -13%
Zurich Cantonal Bank
122
Zurich Cantonal Bank
Switzerland
$60K +$63.8K +815 New
Lazard Asset Management
123
Lazard Asset Management
New York
$51K +$54.4K +695 New
Macquarie Group
124
Macquarie Group
Australia
$28K -$9.24K -118 -23%
Osaic Holdings
125
Osaic Holdings
Arizona
$19K +$19.9K +254 New
2 3 4
5
6

SWTX Hedge Fund Activity: Q1 2021 in Review

137 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q1 2021, worth a combined $3.23B — up 3.3% from $3.13B a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new SWTX positions and 12 closed out — a net gain of 13 holders — while 51 added to existing stakes and 46 trimmed.

The largest buyer was Vanguard Group, adding an estimated $95.8M. The largest seller was Bain Capital Life Sciences Investors, cutting an estimated $114M.

  • 137 institutional investors held SpringWorks Therapeutics (SWTX) as of Q1 2021, up from 124 in Q4 2020.
  • Funds reported $3.23B of SpringWorks Therapeutics stock for Q1 2021, up 3.3% quarter-over-quarter.
  • 25 funds opened new SpringWorks Therapeutics positions in Q1 2021 and 12 closed out, a net change of +13 holders.
  • The largest SpringWorks Therapeutics buyer in Q1 2021 was Vanguard Group, an estimated $95.8M added.
  • The largest SpringWorks Therapeutics seller in Q1 2021 was Bain Capital Life Sciences Investors, an estimated $114M sold.

Based on aggregated 13F filings for Q1 2021.